Leyuan Xu

MedicineMaterials ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Biomarkers of inflammation and repair in kidney disease progression”.

Biomarkers of inflammation and repair in kidney disease progression

Journal of Clinical Investigation(2020)10.1172/jci139927

N/A

0DataRank · unranked

187 citations

Heather Thiessen‐Philbrook, Leyuan Xu, Steven G. Coca, Amit X. Garg, Jonathan Himmelfarb +12 more

Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation

Journal of the American Society of Nephrology(2021)10.1681/asn.2021040439

N/A

0DataRank · unranked

65 citations

Leyuan Xu, Heino Velázquez, Tian-Min Chen, Ryan M. Williams, Daniel A. Heller +4 more

Immune-mediated tubule atrophy promotes acute kidney injury to chronic kidney disease transition

Nature Communications(2022)10.1038/s41467-022-32634-0

N/A

0DataRank · unranked

84 citations

Jian-Kan Guo, Dennis G. Moledina, Lloyd G. Cantley, Leyuan Xu

Arginase-1 Is Required for Macrophage-Mediated Renal Tubule Regeneration

Journal of the American Society of Nephrology(2022)10.1681/asn.2021121548

N/A

0DataRank · unranked

51 citations

Arnaud Marlier, Leyuan Xu, Natnael Doilicho, Daniel Linberg, Jian-Kan Guo +2 more

Immune-mediated Tubule Atrophy Promotes Acute Kidney Injury to Chronic Kidney Disease Transition

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.01.494328

N/A

0DataRank · unranked

7 citations

Jian-Kan Guo, Dennis G. Moledina, Lloyd G. Cantley, Leyuan Xu

Inflammation-mediated Upregulation of VCAM-1 but not KIM-1 during Acute Kidney Injury to Chronic Kidney Disease Transition

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.15.508151

N/A

0DataRank · unranked

4 citations

Kailin Guo, Jian-Kan Guo, Leyuan Xu, Isabel Melchinger

Longitudinal biomarkers and kidney disease progression after acute kidney injury

JCI Insight(2023)10.1172/jci.insight.167731

N/A

0DataRank · unranked

60 citations

Leyuan Xu, Isabel Melchinger, Heather Thiessen‐Philbrook, Dennis G. Moledina, Steven G. Coca +12 more

The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events

Kidney International(2023)10.1016/j.kint.2023.08.007

N/A

0DataRank · unranked

28 citations

Yumeng Wen, Leyuan Xu, Dennis G. Moledina, Heather Thiessen‐Philbrook, David Hu +15 more

Engineering polyamidoamine dendrimer nanoparticles for targeted drug delivery to proximal tubular cells after renal ischemia/reperfusion injury

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114323

N/A

0DataRank · unranked

2 citations

Lloyd G. Cantley, Leyuan Xu, Xiaoxu Li

Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction

Nature Communications(2025)10.1038/s41467-025-67854-7

N/A

0DataRank · unranked

0 citations

Vinod Kumar, Qisheng Lin, Nallakandi Rajeevan, Khadija Banu, Zeguo Sun +17 more